Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Alex Preston

12PUBLICATIONS
46CO-AUTHORS
Molecular targetsGenome structure and regulationCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

Sort by Publication Date:
|Dec 30, 2025
BET Isoform Selectivity through Diverse Linkers for Bivalent Inhibitors: GSK785, a BRD2/4-Selective Bivalent BET Inhibitor.

Francesco Rianjongdee, Stephen J Atkinson, Paul Bamborough

|Apr 16, 2025
Discovery of Highly Potent BET Inhibitors based on a Tractable Tricyclic Scaffold.

Jaffer M Zaidi, Eleonora Comeo, Andrew Baxter

|Sep 22, 2023
Design and Characterization of 1,3-Dihydro-2<i>H</i>-benzo[<i>d</i>]azepin-2-ones as Rule-of-5 Compliant Bivalent BET Inhibitors.

Paul Bamborough, Chun-Wa Chung, Nicole C Goodwin

|Jan 07, 2022
Design, Synthesis, and Characterization of I-BET567, a Pan-Bromodomain and Extra Terminal (BET) Bromodomain Oral Candidate.

Philip G Humphreys, Stephen J Atkinson, Paul Bamborough

|Jul 14, 2021
Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent, Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET) Inhibitors.

Simon C C Lucas, Stephen J Atkinson, Chun-Wa Chung

|Jul 13, 2021
Fragment-based Scaffold Hopping: Identification of Potent, Selective, and Highly Soluble Bromo and Extra Terminal Domain (BET) Second Bromodomain (BD2) Inhibitors.

Jonathan T Seal, Stephen J Atkinson, Paul Bamborough

Pageof 2

Frequent Collaborators

10 joint publications

Chun-Wa Chung

9 joint publications

Emmanuel H Demont

8 joint publications

Stephen J Atkinson

8 joint publications

Paul Bamborough

6 joint publications

Jonathan T Seal

4 joint publications

Lee A Harrison

3 joint publications

Francesco Rianjongdee

2 joint publications

Christopher Wellaway

1 joint publications

Omer Gilan

1 joint publications

Inmaculada Rioja

Frequent Collaborators

10 joint publications

Chun-Wa Chung

9 joint publications

Emmanuel H Demont

8 joint publications

Stephen J Atkinson

8 joint publications

Paul Bamborough

Top Related Videos

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on : Nov 09, 2020

10.9K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on : Oct 26, 2015

11.2K
See more related videos

Top Related Videos

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on : Nov 09, 2020

10.9K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on : Oct 26, 2015

11.2K
See more related videos